Revenue segments as reported by the company.

Smokeable Products

Oral Tobacco Products

Wine

All Other

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Marketing, administration and research costs

Asset impairment and exit costs

Amortization of intangibles

General corporate expenses

Corporate asset impairment and exit costs

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Altria

Altria Group, Inc. operates as a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral tobacco products, and Wine. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral tobacco products segment is primarily moist smokeless tobacco products (MSTs) through brands like Copenhagen and Skoal as well as on! oral nicotine pouches sold by Helix. The Wine segment, through subsidiary Ste. Michelle Wine Estates Ltd, produces Washington State wines, primarily Chateau Ste. Michelle and 14 Hands, and owns wineries in or distributes wines from several other wine regions. The company was founded in 1919 and is headquartered in Richmond, VA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Altria reports robust Q4 earnings, focuses on innovation and growth

Altria's Q4 2022 performance reflects resilience amidst industry challenges, with a focus on innovation and shareholder returns. The company's strategic initiatives in smoke-free products and digital engagement underscore its commitment to long-term growth and harm reduction.

Altria reports resilient Q1 performance amid industry challenges and opportunities

Altria's Q1 2023 earnings call highlighted strong performance amidst industry challenges, emphasizing harm reduction and regulatory compliance. The company faces hurdles from inflation, regulatory changes, and evolving consumer behaviors, while focusing on growth opportunities in smoke-free products and strategic investments.

Altria reports solid Q2 earnings, eyes e-vapor growth opportunities

Altria's focus on smoke-free products and NJOY acquisition driving growth.
Challenges in the cigarette industry due to economic pressures and flavor bans.
Opportunities in the e-vapor category and expansion plans in the U.S.
Strong balance sheet and significant capital returns to shareholders.

Altria reports growth in earnings, navigates regulatory challenges in e-vapor

Altria's Q3 2023 earnings call highlighted solid financial performance, strategic focus on e-vapor products, and efforts to combat illegal vape products. The company faces challenges from regulatory uncertainties and illicit products but sees opportunities in expanding NJOY's reach and addressing market gaps.

Altria reports growth in smoke-free products amidst regulatory challenges

Altria's Q4 2023 earnings call highlighted growth in adjusted EPS, strategic focus on smoke-free products, and efforts to combat illicit e-vapor products. The company faces challenges in competitive segments and economic pressures but sees opportunities in new product introductions and regulatory collaborations.

Altria reports mixed Q1 performance, focuses on growth strategies

Altria's Q1 performance showed growth in NJOY and oral tobacco segments, with challenges in EPS decline and economic pressures on consumers.
Strengths include reaffirmed EPS guidance, strategic investments, and focus on combating illicit e-vapor products.
Opportunities lie in maximizing profitability in oral tobacco, product positioning, and capturing transitioning consumers.
Overall, Altria's performance reflects a mix of growth, challenges, and strategic opportunities in navigating market dynamics.

Altria's NJOY drives growth as company navigates e-vapor challenges

Altria's Q2 2024 earnings call showcased strong performance in smoke-free products, highlighting growth in retail share and volume momentum. Despite challenges in the e-vapor category, the company remains focused on responsible regulation and enforcement. With a commitment to shareholder value and long-term growth strategies, Altria is poised for continued success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Altria Group, Inc. is a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral Tobacco Products, and All Other. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA, and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral Tobacco Products segment includes MST and snus products manufactured and sold by USSTC, and oral nicotine pouches manufactured and sold by Helix. The All Other segment refers to the financial results of NJOY, Helix ROW, and the IQOS System heated tobacco business. The company was founded in 1919 and is headquartered in Richmond, VA.

Concerns over teen e-cig usage drives industry leader to assert greater control over access.

E-Cig Maker Juul Eyes Its Own Retail Store Chain

Cronos Group

Cronos Group Inc (NASDAQ: CRON) CEO Mike Gorenstein presented Tuesday at the Consumer Analyst Group of New York lunch.

Analyst: Cronos And Altria Make A Powerful Team

On Monday the U.S. tobacco giant Altria Group Inc. (NYSE:MO) informed the market that it will acquire an 80% interest in certain companies of the Swiss group Burger Söhne Holding for a total consideration of $372 million.

Altria Group Upgrades Its Smokeless Portfolio With On! Products

Altria (MO) is undertaking efforts to expand in the RRPs space amid receding cigarette shipping volumes.

Can Smokeless Unit Help Altria Pare Low Cigarette Sales?

Altria Group, Inc. (NYSE: MO) has entered into definitive agreements with the shareholders of Switzerland-based, Burger Söhne Holding AG to acquire 80-percent ownership of certain companies of the Burger Group that will commercialize “on!

Altria Buys 80% Stake In Non-Tobacco Oral Nicotine Pouch Company, on!

Altria Group Inc. MO, -2.29% said Monday it reached a deal to invest $372 million to acquire 80% ownership of certain companies of Switzerland-based Burger Sohne Holding AG that will commercialize the oral tobacco-derived nicotine (TDN) pouch product "on!

Altria invests $372 million for stake in oral nicotine pouch 'on!' maker Burger Group

Altria will invest $372 million to sell On, an oral-derived nicotine pouch brand, adding another nicotine product to its growing portfolio.

Altria invests $372 million in Swiss tobacco company Burger Sohne as cigarette sales fall

Philip Morris

Heated tobacco may not be enough to displace the runaway e-cig leader.

Can Philip Morris International's IQOS Really Beat Juul's E-Cigarette?

British American Tobacco

Since Friday, Altria Group Inc. (MO), Philip Morris International Inc.

Big Tobacco Takes a Big Hit (MO) (PM) (BTI) (Revised)

Juul Labs Inc is considering opening retail stores in the United States, a source familiar with the matter said on Thursday, a move that would help the controversial company cash in on the booming popularity of its e-cigarettes.

Juul considers opening retail stores in United States: source

E-cigarette maker and vape company Juul Labs is exploring plans to open its own U.S.

Report: Juul Could Open Its Own US Stores

E-cigarette maker Juul Labs is considering opening U.S. retail shops that would admit only adults, a person familiar with the situation tells CNBC on Thursday.

Juul is exploring plans to open its own US stores: WSJ, citing sources

Senate Minority Whip Dick Durbin in a scathing letter to Acting Food and Drug Administration Commissioner Ned Sharpless said he feels Sharpless has "no intention" of tackling what his predecessor Scott Gottlieb labeled an "epidemic" of teen vaping.

Sen. Durbin blasts FDA on Juul. Says agency 'has no intention' of curbing teen vaping

Ford Motor Company

Occidental Petroleum

AT&T

For the first time in a very long time, the federal funds rate of 2.5% is higher than the yield on the 10-year Treasury, which is at a 20-month low of 2.25%.

As Yields Plunge to Lows, 4 Blue Chips Sport Incredible 6% Dividends

Shares of the big three tobacco stocks continued trading lower after Nielsen data published Tuesday showed a drop in cigarette sales for the four-week period ended May 18.

Tobacco Stocks Trading Lower After Nielsen Data Shows Drop in Cigarette Sales

Tobacco stocks slid Tuesday after new Nielsen data showed cigarette sales volumes declined 11.2% in the past month, according to Nielsen.

Tobacco stocks tumble as cigarette sales decline

Altria (MO) reported earnings 30 days ago. What's next for the stock?

Altria (MO) Up 1.9% Since Last Earnings Report: Can It Continue?

There is enough support to carry MO through bad news.

Collect Income on Altria While it’s Down

Juul Labs is opening its books to overseas investors as it looks to raise cash ahead of a global growth spurt, The Post has learned.

Juul Labs quietly considering overseas financing round

Almost half of the people who followed Juul Labs Inc on Twitter last year were not old enough to legally purchase e-cigarettes in the United States, according to a study published on Monday.

Most of Juul’s Twitter followers are teens who can’t buy e-cigs

Twitter

(Reuters Health) - Almost half of the people who followed Juul Labs Inc on Twitter were not old enough to legally purchase e-cigarettes in the United States, according a study published on Monday.

Nearly half of Juul's Twitter followers are too young to buy e-cigarettes: study

Novartis

Constellation Brands

Forget the volatile marijuana stocks. Their partners could be a better and safer investment for most investors.

3 Ways to Buy Into the Marijuana Boom Without the Risk

Despite criticisms that it’s helping promote an “epidemic” in teen vaping, e-cigarette maker Juul continues to attract new investors, The Post has learned.

JUUL e-cigarette maker sees its valuation top $38B

Altria shareholders grilled CEO Howard Willard on his $12.8 billion bet on e-cigarette giant Juul at the company's annual shareholder meeting Thursday.

Investors grill Altria CEO over $12.8 billion bet on e-cigarette giant Juul

Aurora Cannabis

Though perfectly legal, these accounting tricks are masking the true operating results of many pot stocks.

News for Altria Stock (MO)